Beverly A. Ellis

1.6k total citations
41 papers, 1.3k citations indexed

About

Beverly A. Ellis is a scholar working on Immunology, Molecular Biology and Toxicology. According to data from OpenAlex, Beverly A. Ellis has authored 41 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 14 papers in Molecular Biology and 12 papers in Toxicology. Recurrent topics in Beverly A. Ellis's work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (12 papers), Forensic Toxicology and Drug Analysis (12 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Beverly A. Ellis is often cited by papers focused on Neutrophil, Myeloperoxidase and Oxidative Mechanisms (12 papers), Forensic Toxicology and Drug Analysis (12 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Beverly A. Ellis collaborates with scholars based in United States, Australia and Japan. Beverly A. Ellis's co-authors include Terence J. Dawson, Sergio Catz, Jennifer L. Johnson, Daniela B. Munafó, Kim D. Janda, Agnieszka A. Brzezinska, Bin Zhou, John T. Curnutte, Paul G. Heyworth and Deborah Noack and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Beverly A. Ellis

41 papers receiving 1.2k citations

Peers

Beverly A. Ellis
Mariano Loza‐Coll United States
Paco Hulpiau Belgium
Jennifer L. Johnson United States
Randal C. Jaffe United States
B A White United States
Vibeke Dantzer United Kingdom
Mariano Loza‐Coll United States
Beverly A. Ellis
Citations per year, relative to Beverly A. Ellis Beverly A. Ellis (= 1×) peers Mariano Loza‐Coll

Countries citing papers authored by Beverly A. Ellis

Since Specialization
Citations

This map shows the geographic impact of Beverly A. Ellis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beverly A. Ellis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beverly A. Ellis more than expected).

Fields of papers citing papers by Beverly A. Ellis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beverly A. Ellis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beverly A. Ellis. The network helps show where Beverly A. Ellis may publish in the future.

Co-authorship network of co-authors of Beverly A. Ellis

This figure shows the co-authorship network connecting the top 25 collaborators of Beverly A. Ellis. A scholar is included among the top collaborators of Beverly A. Ellis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beverly A. Ellis. Beverly A. Ellis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Park, Hyeri, et al.. (2022). A Vaccine against Benzimidazole-Derived New Psychoactive Substances That Are More Potent Than Fentanyl. Journal of Medicinal Chemistry. 65(3). 2522–2531. 12 indexed citations
2.
Park, Hyeri, et al.. (2021). Improvements on a chemically contiguous hapten for a vaccine to address fentanyl-contaminated heroin. Bioorganic & Medicinal Chemistry. 41. 116225–116225. 8 indexed citations
3.
Bremer, Paul T., et al.. (2020). Sulfonate-isosteric replacement examined within heroin-hapten vaccine design. Bioorganic & Medicinal Chemistry Letters. 30(17). 127388–127388. 5 indexed citations
4.
Lin, Mingliang, et al.. (2020). Broadly Neutralizing Synthetic Cannabinoid Vaccines. SHILAP Revista de lepidopterología. 1(1). 31–40. 14 indexed citations
5.
Hwang, Candy S., Lauren C. Smith, Cody J. Wenthur, et al.. (2019). Heroin vaccine: Using titer, affinity, and antinociception as metrics when examining sex and strain differences. Vaccine. 37(30). 4155–4163. 16 indexed citations
6.
Hwang, Candy S., Lauren C. Smith, Yoshihiro Natori, et al.. (2018). Improved Admixture Vaccine of Fentanyl and Heroin Hapten Immunoconjugates: Antinociceptive Evaluation of Fentanyl-Contaminated Heroin. ACS Omega. 3(9). 11537–11543. 28 indexed citations
7.
Hwang, Candy S., Beverly A. Ellis, Bin Zhou, & Kim D. Janda. (2018). Heat shock proteins: A dual carrier-adjuvant for an anti-drug vaccine against heroin. Bioorganic & Medicinal Chemistry. 27(1). 125–132. 11 indexed citations
8.
Wenthur, Cody J., Xiaoqing Cai, Beverly A. Ellis, & Kim D. Janda. (2017). Augmenting the efficacy of anti-cocaine catalytic antibodies through chimeric hapten design and combinatorial vaccination. Bioorganic & Medicinal Chemistry Letters. 27(16). 3666–3668. 5 indexed citations
9.
Zhou, Bin, et al.. (2016). Studies towards the improvement of an anti-cocaine monoclonal antibody for treatment of acute overdose. Bioorganic & Medicinal Chemistry Letters. 26(20). 5078–5081. 1 indexed citations
10.
Lockner, Jonathan W., et al.. (2016). Investigations of Enantiopure Nicotine Haptens Using an Adjuvanting Carrier in Anti-Nicotine Vaccine Development. Journal of Medicinal Chemistry. 59(6). 2523–2529. 16 indexed citations
11.
Eubanks, Lisa M., Beverly A. Ellis, Xiaoqing Cai, Joel E. Schlosburg, & Kim D. Janda. (2014). A human recombinant monoclonal antibody to cocaine: Preparation, characterization and behavioral studies. Bioorganic & Medicinal Chemistry Letters. 24(19). 4664–4666. 6 indexed citations
12.
Johnson, Jennifer L., Agnieszka A. Brzezinska, Tanya Tolmachova, et al.. (2009). Rab27a and Rab27b Regulate Neutrophil Azurophilic Granule Exocytosis and NADPH oxidase Activity by Independent Mechanisms. Traffic. 11(4). 533–547. 88 indexed citations
13.
Munafó, Daniela B., Jennifer L. Johnson, Agnieszka A. Brzezinska, et al.. (2009). DNase I Inhibits a Late Phase of Reactive Oxygen Species Production in Neutrophils. Journal of Innate Immunity. 1(6). 527–542. 49 indexed citations
15.
Brzezinska, Agnieszka A., Jennifer L. Johnson, Daniela B. Munafó, et al.. (2008). The Rab27a Effectors JFC1/Slp1 and Munc13‐4 Regulate Exocytosis of Neutrophil Granules. Traffic. 9(12). 2151–2164. 70 indexed citations
16.
Munafó, Daniela B., Jennifer L. Johnson, Beverly A. Ellis, et al.. (2007). Rab27a is a key component of the secretory machinery of azurophilic granules in granulocytes. Biochemical Journal. 402(2). 229–239. 73 indexed citations
17.
Huang, Jeannie S., Deborah Noack, Julie Rae, et al.. (2004). Chronic granulomatous disease caused by a deficiency in p47phox mimicking Crohn’s disease. Clinical Gastroenterology and Hepatology. 2(8). 690–695. 43 indexed citations
18.
Heyworth, Paul G., John M. Robinson, Jiabing Ding, Beverly A. Ellis, & John A. Badwey. (1997). Cofilin undergoes rapid dephosphorylation in stimulated neutrophils and translocates to ruffled membranes enriched in products of the NADPH oxidase complex. Evidence for a novel cycle of phosphorylation and dephosphorylation. Histochemistry and Cell Biology. 108(3). 221–233. 70 indexed citations
20.
MacMillen, Richard E., M. L. Augee, & Beverly A. Ellis. (1989). Thermal ecology and diet of some xerophilous lizards from western New South Wales. Journal of Arid Environments. 16(2). 193–201. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026